This preprint reports a translational investigation into whether residual Borrelia burgdorferi protein antigens persist in peripheral monocyte subsets after antibiotic treatment and whether antigen persistence correlates with persistent immune alterations in people with post-treatment Lyme disease syndrome (PTLDS). The work seeks to distinguish antigen-fueled immune remodeling from ongoing replicating infection as a driver of PTLDS symptoms.
The authors aimed to determine whether Borrelia protein antigens remain present in long-lived monocyte subsets months to years after treatment, and to assess whether antigen presence is associated with broader immune dysregulation. The rationale rests on competing hypotheses for PTLDS pathogenesis: persistent low-level infection, autoimmunity, or immune dysregulation driven by residual microbial antigens. The study tested for both protein antigen and bacterial transcript in monocytes and profiled systemic and cellular immune signatures.
Ten participants with PTLDS contributed samples for this study. CD14⁺CD16⁺ monocytes isolated from these participants were analyzed by mass spectrometry to search for Borrelia proteins. Plasma from all 10 participants was assayed on a 14-plex cytokine panel and compared against measurements from 50 healthy donors. Peripheral blood mononuclear cells (PBMCs) from six participants—three antigen-positive and three antigen-negative by mass spectrometry—underwent RT-qPCR and bulk RNA sequencing with immune-compartment profiling to define transcriptional changes and shifts across immune cell compartments.
Mass spectrometry identified the Borrelia proteins FlaB (flagellin B) and OspC (outer surface protein C) within purified CD14⁺CD16⁺ monocytes from PTLDS participants. These protein antigens were detected months to years following antibiotic therapy. In contrast, surveillance for Borrelia burgdorferi transcript by RT-qPCR did not detect bacterial RNA in the tested samples, indicating an absence of detectable replicating bacteria in those assays.
Across the ten PTLDS participants, plasma IFN-γ concentrations exceeded the median value observed in the 50 healthy donor comparator cohort. This consistent elevation of IFN-γ occurred regardless of antigen-positive status by mass spectrometry. The paper reports plasma cytokine profiling via a 14-plex panel but does not provide additional numerical cytokine values in the abstract; details are available in the article and supplemental material.
Bulk RNA-seq analysis of PBMCs from the subset of six participants revealed an antigen-associated inflammatory transcriptional profile in antigen-positive samples. Genes with increased expression in antigen-positive samples included TNFSF14 (also called LIGHT), GSDMD, GBP5, and KCNJ2. Immune-compartment profiling identified a pattern the authors describe as a monocyte-skewed myeloid reconfiguration, accompanied by elevated neutrophil-related features and selective changes in T-cell states. These findings suggest that the presence of Borrelia protein antigen in monocytes is associated with durable remodeling of innate and adaptive immune compartments.
The authors interpret their findings as supporting a model in which residual, non-replicating Borrelia burgdorferi protein antigens embedded in long-lived monocyte subsets fuel sustained immune activation and remodeling in PTLDS, rather than ongoing active infection. They note parallels between these observations and similar patterns reported in other post-infectious syndromes, including long COVID, where antigen persistence has been linked to immune dysregulation.
This report is a preprint and has not been peer reviewed; it should not be used to guide clinical care. The study sample sizes are modest (10 participants for antigen detection and cytokine profiling; 6 for RNA-seq comparisons); further details and full datasets are provided in the article and supplemental material. The authors declare competing interests: several authors are employees of HealthBio Inc., and collaborators are affiliated with Caucell Inc., which developed the Immunogram platform used here. Ethical approval was provided by the Ethics IRB of the Chronic COVID Treatment Center (protocol CCTC-008), and participants provided written informed consent. RNA sequencing data have been deposited in NCBI GEO under accession GSE348165.
Clinicians and researchers should interpret these findings as preliminary and hypothesis-generating pending peer review and replication in larger, independent cohorts. The results describe an association between persistent Borrelia protein antigen in CD14⁺CD16⁺ monocytes and monocyte-skewed immune remodeling in PTLDS, with no detectable Borrelia transcript in the tested samples.